Search results
Epinephrine
Investigation of congenital (e.g., Glanzmann’s thrombasthenia, gray platelet syndrome) or acquired thrombopathy (e.g. myelodisplasic or myeloproliferative syndrome, Waldenström’s disease, multiple myeloma). Follow-up of patients treated with antiplatelet drugs such as aspirin, thienopyridines, abciximab and other NSAIDsand GPIIb/IIIa inhibitors.
Factor II (Fragment 1), Human
Factor II (Fragment 2), Human
Factor II (Prothrombin) Deficient Plasma
Measurement of factor II (FII / prothrombin) activity in human citrated plasma using a clotting method, triggered with calcium thromboplastin. For any in vitro protocol or research study where a source of human prothrombin deficient plasma is required.
Factor II (Prothrombin) Deficient Plasma
Measurement of Factor II (FII / prothrombin) activity in human citrated plasma using a clotting method, triggered with calcium thromboplastin. For any in vitro protocol or research study where a source of human prothrombin deficient plasma is required.
Factor II (Prothrombin), anti-human, mouse, IgG
Factor II (Prothrombin), anti-human, sheep, Fragment-1, IgG, affinity purified
Factor II (Prothrombin), anti-human, sheep, Fragment-2, IgG, affinity purified
Factor II (Prothrombin), anti-human, sheep, IgG, affinity purified
Factor II (Prothrombin), anti-human, sheep, IgG, purified